Article Information
History
- March 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ilies Benotmane, MD1,2,*,
- Gabriela Gautier-Vargas, MD1,
- Noelle Cognard, MD1,
- Jerome Olagne, MD1,
- Francoise Heibel, MD1,
- Laura Braun-Parvez, MD1,
- Jonas Martzloff, MD1,
- Peggy Perrin, MD1,
- Bruno Moulin, MD, PhD1,2,
- Samira Fafi-Kremer, MD, PhD2,3 and
- Sophie Caillard, MD, PhD1,2
- 1Department of Nephrology and Transplantation, University Hospital, Strasbourg, France
- 2Fédération de Médecine Translationnelle (FMTS), Strasbourg, France
- 3Department of virology, University Hospital, Strasbourg, France
- ↵*Corresponding author: Ilies Benotmane, Department of Nephrology and Transplantation, Strasbourg University Hospital, 1 Place de l’Hopital, 67091 Strasbourg, Cedex, France. E-mail address: Ilies.benotmane{at}chru-strasbourg.fr
Posted March 12, 2021.
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
